CONJUGATED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Conjugated, and when can generic versions of Conjugated launch?
Conjugated is a drug marketed by Novast Labs and is included in two NDAs.
The generic ingredient in CONJUGATED is estrogens, conjugated. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estrogens, conjugated profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CONJUGATED?
- What are the global sales for CONJUGATED?
- What is Average Wholesale Price for CONJUGATED?
Summary for CONJUGATED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | CONJUGATED at DailyMed |
US Patents and Regulatory Information for CONJUGATED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214025-001 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214023-001 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214025-002 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214025-003 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novast Labs | CONJUGATED ESTROGENS | estrogens, conjugated | TABLET;ORAL | 214023-002 | Oct 15, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
